Showing results (51-60 of 144) with videos related to
Sort By:
Pageof 15
Cancer|January 12, 2013
A phase 2 study of epothilone B analog BMS-247550 (NSC 710428) in patients with relapsed aggressive non-Hodgkin lymphomasJane E Churpek, Barbara Pro, Koen van Besien, et al.Cancer Biology & Therapy|June 9, 2006
A phase II trial of perifosine, an oral alkylphospholipid, in recurrent or metastatic head and neck cancerAthanassios Argiris, Ezra Cohen, Theodore Karrison, et al.American Journal of Clinical Pathology|January 11, 2007
Therapy-related myelodysplastic syndrome: morphologic subclassification may not be clinically relevantZeba N Singh, Dezheng Huo, John Anastasi, et al.The Journal of Urology|January 21, 2014
Early removal of urethral catheter with suprapubic tube drainage versus urethral catheter drainage alone after robot-assisted laparoscopic radical prostatectomySandip M Prasad, Michael C Large, Amit R Patel, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 2008
Dynamic contrast-enhanced magnetic resonance imaging pharmacodynamic biomarker study of sorafenib in metastatic renal carcinomaOlwen M Hahn, Cheng Yang, Milica Medved, et al.Environment International|November 15, 2016
Effect of a clean stove intervention on inflammatory biomarkers in pregnant women in Ibadan, Nigeria: A randomized controlled studyChristopher O Olopade, Elizabeth Frank, Emily Bartlett, et al.The Journal of Urology|December 8, 2025
Randomized, Prospective Evaluation of Hemostatic Agents in Robotic-Assisted Laparoscopic Partial NephrectomyAlon Lazarovich, Samuel Tremblay, Charlie Nottingham, et al.Clinical Lung Cancer|November 22, 2011
Targeted and cytotoxic therapy in coordinated sequence (TACTICS): erlotinib, bevacizumab, and standard chemotherapy for non-small-cell lung cancer, a phase II trialEzra E W Cohen, Janakiraman Subramanian, Feng Gao, et al.Oncotarget|February 14, 2018
Clinical and molecular features of innate and acquired resistance to anti-PD-1/PD-L1 therapy in lung cancerShalin Shah, Kevin Wood, Brian Labadie, et al.Clinical Genitourinary Cancer|September 17, 2016
Dynamic Contrast-Enhanced Magnetic Resonance Imaging as a Pharmacodynamic Biomarker for Pazopanib in Metastatic Renal CarcinomaRandy F Sweis, Milica Medved, Shannon Towey, et al.Pageof 15